Sars-cov-2 Disease

• CLINICAL_TRIALS trial_result · 2024-02-20
  Clinical Trial Update: A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults [Phase 1, Phase 2]

  A Phase 1/2 clinical trial of Covigenix VAX-001, a prophylactic plasmid DNA vaccine for SARS-CoV-2, has completed.

• CLINICAL_TRIALS trial_result · 2023-10-06
  Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 [Phase 3]

  Phase 3 trial evaluating CVnCoV vaccine safety and immunogenicity in healthy adults completed; results posted in 2023.

• CLINICAL_TRIALS trial_result · 2020-05-20
  Clinical Trial Update: Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19) [Phase 3]

  A Phase 3 clinical trial investigating convalescent plasma for treatment of severe SARS-CoV-2 (COVID-19) is underway with unknown status.